Lantheus Holdings (LNTH) Operating Income (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Operating Income of $81.3 million for Q1 2026, down 20.32% year-over-year from $102.1 million in Q1 2025, and up 5.37% quarter-over-quarter from $77.2 million in Q4 2025.
Lantheus Holdings (LNTH) Operating Income (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Operating Income for 13 consecutive years, with $81.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 20.32% year-over-year to $81.3 million; the TTM figure through Mar 2026 stood at $290.1 million (down 35.88% YoY), while the FY2025 annual figure was $310.8 million, down 31.98% from the prior year.
- Operating Income improved to $81.3 million in Q1 2026 per LNTH's latest filing, from $77.2 million in the prior quarter.
- Across five years, Operating Income topped out at $137.5 million in Q4 2023 and bottomed at -$171.7 million in Q4 2022.
- Historically, Operating Income has averaged $73.5 million across 5 years, with a median of $88.0 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Income sank 385.81% — and 2024, when it surged 1241.21%.
- Lantheus Holdings' Operating Income stood at -$171.7 million in 2022, then surged by 180.08% to $137.5 million in 2023, then slipped by 17.18% to $113.9 million in 2024, then sank by 32.22% to $77.2 million in 2025, then gained by 5.37% to $81.3 million in 2026.
- Business Quant data shows LNTH's Operating Income at $81.3 million in Q1 2026, $77.2 million in Q4 2025, and $43.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 100.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.22 Mn |
| Mar 31, 2026 | 81.33 Mn |
| Dec 31, 2025 | 77.18 Mn |
| Sep 30, 2025 | 43.62 Mn |
| Jun 30, 2025 | 87.97 Mn |
| Mar 31, 2025 | 102.07 Mn |
| Dec 31, 2024 | 113.87 Mn |
| Sep 30, 2024 | 133.74 Mn |
| Jun 30, 2024 | 102.73 Mn |
| Mar 31, 2024 | 106.64 Mn |
| Dec 31, 2023 | 137.49 Mn |
| Sep 30, 2023 | 112.36 Mn |
| Jun 30, 2023 | 124.14 Mn |
| Mar 31, 2023 | -9.34 Mn |
| Dec 31, 2022 | -171.68 Mn |
| Sep 30, 2022 | 85.74 Mn |
| Jun 30, 2022 | 63.20 Mn |
| Mar 31, 2022 | 58.93 Mn |
| Dec 31, 2021 | -35.34 Mn |
| Sep 30, 2021 | -14.33 Mn |